Skip to main content
. 2020 Nov 18;9(11):3706. doi: 10.3390/jcm9113706
CT computed tomography
DAB 3,3′-diaminobenzidine
DIILD drug-induced interstitial lung disease
ECM extracellular matrix
FDG fludeoxyglucose
FOV field of view
HRCT high resolution computed tomography
H&E hematoxylin and Eosin
IBs imaging biomarkers
IL interleukin
ILD interstitial lung disease
IPF idiopathic pulmonary fibrosis
i.t. intratracheal
LBIC Lund university BioImaging Centre
LOX Lysyl Oxidase
MMPs Matrix metallopeptidases
MRI magnetic resonance imaging
PET positron emission tomography
ROI region of interest
TGF-β tissue growth factor β
TIMP1 tissue inhibitor of metalloproteinase 1
TRISTAN-IMI Translational Imaging in Drug Safety Assessment—Innovative Medicines Initiative
UTE ultra short echo time